MSLE
Price
$6.64
Change
-$0.06 (-0.90%)
Updated
Oct 22 closing price
Capitalization
140.88M
22 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$187.69
Change
-$6.59 (-3.39%)
Updated
Oct 22 closing price
Capitalization
40.23B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MSLE vs RVMD

MSLE vs RVMD Comparison Chart in %
View a ticker or compare two or three
VS
MSLE vs. RVMD commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSLE is a Hold and RVMD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MSLE with price predictions
Oct 22, 2026

MSLE sees MACD Histogram crosses below signal line

MSLE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 38 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MSLE as a result. In 79 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

MSLE moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MSLE crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for MSLE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MSLE's RSI Indicator exited the oversold zone, 20 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

MSLE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.352) is normal, around the industry mean (2.973). P/E Ratio (-3.405) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. MSLE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RVMD with price predictions
Oct 22, 2026

RVMD's RSI Oscillator recovers from oversold territory

The RSI Indicator for RVMD moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In 13 of the 14 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 62 cases where RVMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

Following a +10.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVMD advanced for three days, in 245 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

RVMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RVMD as a result. In 62 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for RVMD turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

RVMD moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RVMD crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

The Aroon Indicator for RVMD entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. RVMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.436) is normal, around the industry mean (2.973). P/E Ratio (-21.160) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. RVMD's P/S Ratio (10000.000) is very high in comparison to the industry average of (438.009).

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
MSLE vs RVMD: Fundamental Ratings
MSLE
RVMD
OUTLOOK RATING
1..100
5293
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
1005
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3435
P/E GROWTH RATING
1..100
9946
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MSLE's Valuation (34) in the null industry is somewhat better than the same rating for RVMD (95). This means that MSLE’s stock grew somewhat faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (5) in the null industry is significantly better than the same rating for MSLE (100). This means that RVMD’s stock grew significantly faster than MSLE’s over the last 12 months.

RVMD's SMR Rating (98) in the null industry is in the same range as MSLE (98). This means that RVMD’s stock grew similarly to MSLE’s over the last 12 months.

MSLE's Price Growth Rating (34) in the null industry is in the same range as RVMD (35). This means that MSLE’s stock grew similarly to RVMD’s over the last 12 months.

RVMD's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for MSLE (99). This means that RVMD’s stock grew somewhat faster than MSLE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MSLERVMD
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (MSLE: $6.70 vs. RVMD: $194.28)
Brand notoriety: MSLE and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSLE: 40% vs. RVMD: 88%
Market capitalization -- MSLE: $140.88M vs. RVMD: $40.23B
MSLE [@Biotechnology] is valued at $140.88M. RVMD’s [@Biotechnology] market capitalization is $40.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSLE’s FA Score shows that 0 FA rating(s) are green while RVMD’s FA Score has 1 green FA rating(s).

  • MSLE’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RVMD is a better buy in the long-term than MSLE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSLE’s TA Score shows that 3 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • MSLE’s TA Score: 3 bullish, 6 bearish.
  • RVMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than MSLE.

Price Growth

MSLE (@Biotechnology) experienced а +1.06% price change this week, while RVMD (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

MSLE is expected to report earnings on Nov 13, 2026.

RVMD is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MSLE
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

MSLE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MSLE has been loosely correlated with ANL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MSLE jumps, then ANL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSLE
1D Price
Change %
MSLE100%
-0.90%
ANL - MSLE
40%
Loosely correlated
-6.04%
RVMD - MSLE
30%
Poorly correlated
-3.39%
BNTX - MSLE
29%
Poorly correlated
-1.77%
IPSC - MSLE
25%
Poorly correlated
-1.86%
PRME - MSLE
24%
Poorly correlated
-2.10%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with GLUE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-3.39%
GLUE - RVMD
43%
Loosely correlated
-0.98%
SYRE - RVMD
40%
Loosely correlated
-0.67%
ARRY - RVMD
39%
Loosely correlated
-3.23%
AXON - RVMD
39%
Loosely correlated
+2.98%
REPL - RVMD
38%
Loosely correlated
+2.30%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABG173.439.38
+5.72%
Asbury Automotive Group
FTHM0.19N/A
-0.22%
Fathom Holdings
DT63.37-1.41
-2.18%
Dynatrace
SIDU1.12-0.05
-4.27%
Sidus Space
AVTX7.45-4.81
-39.23%
Avalo Therapeutics